Remote Patient Monitoring (RPM) has become one of the fastest-growing segments of digital health. It is widely promoted as a tool to improve chronic disease management, reduce hospitalizations, and lower healthcare costs. At the same time, RPM has come under increased scrutiny from policymakers, regulators, and payers due to concerns around inconsistent outcomes, program integrity, and fraud.
Despite rapid adoption, there is no comprehensive, consolidated evidence base that evaluates RPM across its most critical dimensions: cost, quality, and fraud. Policy decisions are often made using fragmented studies, anecdotal enforcement actions, or incomplete data. This lack of clarity creates uncertainty for providers, payers, and patients, and risks undermining responsible RPM programs alongside bad actors.
The Center for Telehealth and e-Health Law (CTeL) is launching a targeted meta-analysis of Remote Patient Monitoring to address this gap.
This research initiative will systematically evaluate existing peer-reviewed literature, claims-based analyses, and regulatory reports to assess:
-
The economic impact of RPM, including cost savings and utilization effects
-
Clinical quality outcomes across RPM use cases and patient populations
-
Documented fraud patterns and areas of program vulnerability
The study is intentionally focused on RPM rather than broader remote monitoring, recognizing that RPM represents the majority of current billing volume and has the most mature evidence base for rigorous meta-analysis. This approach ensures the research is actionable, credible, and immediately relevant to current policy debates.
Over a six-week period, CTeL’s research team will conduct a structured literature review, assess study quality and heterogeneity, and synthesize findings into a comprehensive white paper. The final deliverable will include a 6–10 page report with a concise executive summary, data visualizations, and clear policy-relevant conclusions designed to inform regulators, legislators, payers, and industry stakeholders.
This work is essential at a moment when RPM policy is at an inflection point. Enforcement actions are increasing, reimbursement rules are evolving, and lawmakers are seeking evidence to distinguish effective, compliant programs from those driving inappropriate utilization. Without objective, consolidated research, there is a real risk of overcorrection that could limit access to beneficial RPM services.
Your support directly enables this research.
Contributions to CTeL will fund:
-
Independent analysis of RPM cost effectiveness and utilization trends
-
Objective assessment of quality outcomes across diverse RPM models
-
Identification of documented fraud patterns to inform smarter policy responses
-
Evidence-based recommendations that support sustainable, high-integrity RPM adoption
By supporting this initiative, donors help ensure RPM policy is shaped by data rather than headlines, enforcement anecdotes, or incomplete evidence.
This meta-analysis will serve as a foundational resource for future policy development, economic modeling, and stakeholder decision-making. It is designed to clarify what works, what does not, and where targeted reforms are needed to protect patients while preserving innovation.
Join CTeL in bringing clarity, credibility, and balance to the RPM policy conversation.
Donate today to support independent research that informs smarter digital health policy.
